Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 101

    1.

    Complete atrioventricular block and ventricular tachyarrhythmia associated with donepezil.

    Suleyman T, Tevfik P, Abdulkadir G, Ozlem S.

    Emerg Med J. 2006 Aug;23(8):641-2.PMID: 16858101 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    [Symptomatic sinus bradycardia associated with donepezil]

    Calvo-Romero JM, Ramos-Salado JL.

    Rev Neurol. 1999 Jun 1-15;28(11):1070-2. Spanish. PMID: 10390778 [PubMed - indexed for MEDLINE]Related articles

    3.

    Causes of syncope in patients with Alzheimer's disease treated with donepezil.

    Bordier P, Lanusse S, Garrigue S, Reynard C, Robert F, Gencel L, Lafitte A.

    Drugs Aging. 2005;22(8):687-94.PMID: 16060718 [PubMed - indexed for MEDLINE]Related articles

    4.

    Cardiovascular effects and risk of syncope related to donepezil in patients with Alzheimer's disease.

    Bordier P, Garrigue S, Lanusse S, Margaine J, Robert F, Gencel L, Lafitte A.

    CNS Drugs. 2006;20(5):411-7.PMID: 16696580 [PubMed - indexed for MEDLINE]Related articles

    5.

    Donepezil-induced adverse side effects of cardiac rhythm: 2 cases report of atrioventricular block and Torsade de Pointes.

    Tanaka A, Koga S, Hiramatsu Y.

    Intern Med. 2009;48(14):1219-23. Epub 2009 Jul 15.PMID: 19602789 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Significance of syncope in patients with Alzheimer's disease treated with cholinesterase inhibitors.

    Bordier P, Garrigue S, Barold SS, Bressolles N, Lanusse S, Clémenty J.

    Europace. 2003 Oct;5(4):429-31.PMID: 14753643 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Safety and tolerability of donepezil at doses up to 20 mg/day: results from a pilot study in patients with Alzheimer's disease.

    Doody RS, Corey-Bloom J, Zhang R, Li H, Ieni J, Schindler R.

    Drugs Aging. 2008;25(2):163-74.PMID: 18257603 [PubMed - indexed for MEDLINE]Related articles

    8.

    Adverse effects associated with the use of donepezil in general practice in England.

    Dunn NR, Pearce GL, Shakir SA.

    J Psychopharmacol. 2000;14(4):406-8.PMID: 11198060 [PubMed - indexed for MEDLINE]Related articles

    9.

    Complete atrioventricular block associated with rivastigmine therapy.

    Kayrak M, Yazici M, Ayhan SS, Koc F, Ulgen MS.

    Am J Health Syst Pharm. 2008 Jun 1;65(11):1051-3.PMID: 18499878 [PubMed - indexed for MEDLINE]Related articles

    10.

    Donepezil for severe Alzheimer's disease.

    Opie LH.

    Lancet. 2006 Jul 29;368(9533):361-2; author reply 362. No abstract available. PMID: 16876651 [PubMed - indexed for MEDLINE]Related articles

    11.

    Donepezil-related toxic hepatitis.

    Dierckx RI, Vandewoude MF.

    Acta Clin Belg. 2008 Sep-Oct;63(5):339-42.PMID: 19186568 [PubMed - indexed for MEDLINE]Related articles

    12.

    Donepezil: tolerability and safety in Alzheimer's disease.

    Pratt RD, Perdomo CA, Surick IW, Ieni JR.

    Int J Clin Pract. 2002 Nov;56(9):710-7.PMID: 12469988 [PubMed - indexed for MEDLINE]Related articles

    13.

    [Complete atrioventricular block during galantamine therapy]

    Leentjens AF, Kragten JA.

    Ned Tijdschr Geneeskd. 2006 Mar 11;150(10):563-6. Dutch. PMID: 16566422 [PubMed - indexed for MEDLINE]Related articles

    14.

    Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease.

    Doody RS, Geldmacher DS, Gordon B, Perdomo CA, Pratt RD; Donepezil Study Group.

    Arch Neurol. 2001 Mar;58(3):427-33.PMID: 11255446 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Down syndrome and Alzheimer's disease--pilot study.

    Prasher VP, Huxley A, Haque MS; Down syndrome Ageing Study Group.

    Int J Geriatr Psychiatry. 2002 Mar;17(3):270-8.PMID: 11921156 [PubMed - indexed for MEDLINE]Related articles

    16.

    The pharmacology of donepezil: a new treatment of Alzheimer's disease.

    Wilkinson DG.

    Expert Opin Pharmacother. 1999 Nov;1(1):121-35. Review.PMID: 11249555 [PubMed - indexed for MEDLINE]Related articles

    17.

    Donepezil and cardiac syncope: case report.

    Jane Newby V, Anne Kenny R, McKeith IG.

    Int J Geriatr Psychiatry. 2004 Nov;19(11):1110-2. No abstract available. PMID: 15497193 [PubMed - indexed for MEDLINE]Related articles

    18.

    [A case of acute cholinergic adverse effects induced by donepezil overdose: a follow-up of clinical course and plasma concentration of donepezil]

    Yano H, Fukuhara Y, Wada K, Kowa H, Nakashima K.

    Rinsho Shinkeigaku. 2003 Aug;43(8):482-6. Japanese. PMID: 14658400 [PubMed - indexed for MEDLINE]Related articles

    19.

    Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan.

    Homma A, Imai Y, Tago H, Asada T, Shigeta M, Iwamoto T, Takita M, Arimoto I, Koma H, Takase T, Ohbayashi T.

    Dement Geriatr Cogn Disord. 2009;27(3):232-9. Epub 2009 Feb 25.PMID: 19246907 [PubMed - indexed for MEDLINE]Related articles

    20.

    A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.

    Tariot PN, Cummings JL, Katz IR, Mintzer J, Perdomo CA, Schwam EM, Whalen E.

    J Am Geriatr Soc. 2001 Dec;49(12):1590-9.PMID: 11843990 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data